About Index Trending news
Analyze
Pricing
Cempra

Cempra

Cempra

Cempra Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing antibacterials to meet critical medical needs.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Venture capital (Series C)
$46,000,000
Employees

Team size

10+
Xconomy

Antibiotics Firms Cempra, Melinta Therapeutics Agree to Merger

Health
Xconomy

Cempra Soars on Drug’s Potential to Treat MRSA, Other Infections

Health
The Motley Fool

3 Reasons Why Cempra, Inc. Rallied 10.99% in May

The Motley Fool

Why Epizyme Inc, Akebia Therapeutics Inc, and Cempra Inc Got Wacked Today --

Stock markets Health Costs
The Motley Fool

Why Cempra Inc is Up Big Today --

Health Stock markets
Xconomy

Raleigh-Durham Roundup: Biotech Center, AvidExchange, Cempra, & More

Health Funding